Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective

Symposium
Chairs: V. Cottin (Lyon, France), C. Lange (Borstel, Germany)
Aims: The aim of this symposium is to update knowledge and improve evidence-based practice within the pulmonary community regarding rheumatoid arthritis and its treatment.

The lung in rheumatoid arthritis: drugs versus underlying disease A. Churg (Vancouver, Canada)
Drug-induced lung disease in rheumatoid arthritis: critical review of patterns Ph. Camus (Dijon, France)